Related Experiment Videos
Pathophysiology of the MELAS 3243 transition mutation
A Flierl1, H Reichmann, P Seibel
1Wissenschaftliche Nachwuchsgruppe, Theodor Boveri Institut, Biozentrum der Bayerischen-Julius-Maximillians-Universität, Am Hubland, 97074 Würzburg, Federal Republic of Germany.
The Journal of Biological Chemistry
|October 27, 1997
Summary
Mitochondrial DNA mutations, like the A3243G in tRNA-Leu(UUR), impair cellular energy production. This study shows this mutation specifically disrupts leucine incorporation, affecting mitochondrial protein synthesis and function in MELAS syndrome.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Mitochondrial DNA (mtDNA) mutations are linked to metabolic disorders, including myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
- The A3243G mutation in the mitochondrial tRNALeu(UUR) gene is a common cause of MELAS, leading to mitochondrial dysfunction.
Purpose of the Study:
- To investigate the pathophysiology of the A3243G mtDNA mutation.
- To analyze the impact of this mutation on mitochondrial protein synthesis and function.
Main Methods:
- Established Epstein-Barr virus-transformed B-cell lines with 30-70% mutated mtDNA.
- Assessed primary transcript processing and mitochondrial protein subunit synthesis rates.
- Measured cytochrome-c oxidase activity and respiratory complex IV subunit content.
- Quantified amino acid incorporation into mitochondrial proteins and analyzed proteolytic patterns.
Main Results:
- No general impairment in primary transcript processing or overall mitochondrial protein synthesis was observed.
- Cell lines with 70% mutated mtDNA showed decreased cytochrome-c oxidase activity and reduced mitochondrial-encoded subunits in complex IV.
- Specific reduction in leucine incorporation into certain mitochondrial translation products was detected.
- Proteolytic fingerprint patterns varied, supporting altered protein synthesis.
Conclusions:
- The malfunctioning mitochondrial tRNALeu(UUR) specifically impairs amino acid incorporation during mitochondrial protein synthesis.
- This defect alters the structure and function of the oxidative phosphorylation system, contributing to MELAS pathophysiology.